Morgans Senior Analyst Scott Power caught up with Robert Proulx, Chief Executive Officer of Imagion Biosystems, who explained with he joined the company and the technology behind it.
Morgans Under the Microscope Podcast with Bob Proulx
Highlights: Announced preliminary performance of MagSense® HER2 Imaging Agent in phase 1 study after study closure (post quarter end) Entered a strategic partnership with Prestige
Transforming medical imaging for early disease detection
We’re on a mission to make cancer more detectable.